Cargando…

Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study

BACKGROUND: The presence of widespread lung microvascular circulation and abundant connective tissue with a large reserve raises the possibility that the lung may be a target organ of the pathologic processes induced by type 2 diabetes. Pulmonary function tests (PFTs) are noninvasive medical tests t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesema, Dereje Gemeda, Gobena, Teshome, Ayalew, Almaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152549/
https://www.ncbi.nlm.nih.gov/pubmed/32308467
http://dx.doi.org/10.2147/IJGM.S249683
_version_ 1783521503872024576
author Tesema, Dereje Gemeda
Gobena, Teshome
Ayalew, Almaz
author_facet Tesema, Dereje Gemeda
Gobena, Teshome
Ayalew, Almaz
author_sort Tesema, Dereje Gemeda
collection PubMed
description BACKGROUND: The presence of widespread lung microvascular circulation and abundant connective tissue with a large reserve raises the possibility that the lung may be a target organ of the pathologic processes induced by type 2 diabetes. Pulmonary function tests (PFTs) are noninvasive medical tests that show how well the lungs are working. OBJECTIVE: The aim was to compare pulmonary function tests (PFTs) and their associated factors among type 2 diabetic patients and non-diabetics at Jimma Medical Center (JMC). METHODS: A comparative cross-sectional study was conducted at JMC, Jimma, Southwest Ethiopia among 298 study participants from April 1 to May 30, 2019. A face-to-face interview with semi-structured questionnaire was conducted. Forced vital capacity (FVC), forced expiratory volume in one second (FEV(1)), ratio of FEV(1)/FVC, peak expiratory flow (PEF), and forced expiratory flow (FEF(25−75)) were recorded by using a digital Spirometer. Independent samples t-test, simple and multiple linear regression analysis were used. RESULTS: The present study indicated that means of the PFTs among type 2 diabetics were significantly reduced when compared to their matched non-diabetics (FVC (%) (m=73.7±13.8 vs m=93.8±12.3), FEV(1) (%) (m=76.4±13.4 vs m=93.3±12.4), FEV(1)/FVC (%) (m=78.99±11.4 vs m=96.6±9.33), PEF (L/s) (m=3.91±0.28 vs m=5.03±0.35), and FEF(25–75) (L/s) (m=2.89±0.75 vs m=3.39±0.82)). This study also indicated that body mass index (BMI) (β=−1.93, P<0.001) and fasting blood sugar (FBS) (β=−0.22, P<0.001) were negative predictors of FVC%. BMI (β=−1.93, P<0.001) and FBS (β=−0.29, P<0.001) were negative predictors of FEV1%. BMI (β=−1.403, P<0.001) was a negative predictor of mean FEV(1)/FVC. BMI (β=−1.39 P<0.001) and FBS (β=−0.15, P<0.001) were negative predictors of mean PEF (L/s). BMI (β=−0.075, P<0.001) and FBS (β=−0.075, P<0.001) were negative predictors of FEF(25–75) (L/s). CONCLUSION: The present study showed that there were significantly reduced mean scores of FVC, FEV(1), FEV(1)/FVC, PEF, and FEF(25–75) among type 2 diabetic patients as compared to non-diabetic participants. The FBS and BMI were independent risk factors of the PFTs among the diabetics, unlike among non-diabetic participants.
format Online
Article
Text
id pubmed-7152549
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71525492020-04-17 Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study Tesema, Dereje Gemeda Gobena, Teshome Ayalew, Almaz Int J Gen Med Original Research BACKGROUND: The presence of widespread lung microvascular circulation and abundant connective tissue with a large reserve raises the possibility that the lung may be a target organ of the pathologic processes induced by type 2 diabetes. Pulmonary function tests (PFTs) are noninvasive medical tests that show how well the lungs are working. OBJECTIVE: The aim was to compare pulmonary function tests (PFTs) and their associated factors among type 2 diabetic patients and non-diabetics at Jimma Medical Center (JMC). METHODS: A comparative cross-sectional study was conducted at JMC, Jimma, Southwest Ethiopia among 298 study participants from April 1 to May 30, 2019. A face-to-face interview with semi-structured questionnaire was conducted. Forced vital capacity (FVC), forced expiratory volume in one second (FEV(1)), ratio of FEV(1)/FVC, peak expiratory flow (PEF), and forced expiratory flow (FEF(25−75)) were recorded by using a digital Spirometer. Independent samples t-test, simple and multiple linear regression analysis were used. RESULTS: The present study indicated that means of the PFTs among type 2 diabetics were significantly reduced when compared to their matched non-diabetics (FVC (%) (m=73.7±13.8 vs m=93.8±12.3), FEV(1) (%) (m=76.4±13.4 vs m=93.3±12.4), FEV(1)/FVC (%) (m=78.99±11.4 vs m=96.6±9.33), PEF (L/s) (m=3.91±0.28 vs m=5.03±0.35), and FEF(25–75) (L/s) (m=2.89±0.75 vs m=3.39±0.82)). This study also indicated that body mass index (BMI) (β=−1.93, P<0.001) and fasting blood sugar (FBS) (β=−0.22, P<0.001) were negative predictors of FVC%. BMI (β=−1.93, P<0.001) and FBS (β=−0.29, P<0.001) were negative predictors of FEV1%. BMI (β=−1.403, P<0.001) was a negative predictor of mean FEV(1)/FVC. BMI (β=−1.39 P<0.001) and FBS (β=−0.15, P<0.001) were negative predictors of mean PEF (L/s). BMI (β=−0.075, P<0.001) and FBS (β=−0.075, P<0.001) were negative predictors of FEF(25–75) (L/s). CONCLUSION: The present study showed that there were significantly reduced mean scores of FVC, FEV(1), FEV(1)/FVC, PEF, and FEF(25–75) among type 2 diabetic patients as compared to non-diabetic participants. The FBS and BMI were independent risk factors of the PFTs among the diabetics, unlike among non-diabetic participants. Dove 2020-04-08 /pmc/articles/PMC7152549/ /pubmed/32308467 http://dx.doi.org/10.2147/IJGM.S249683 Text en © 2020 Tesema et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tesema, Dereje Gemeda
Gobena, Teshome
Ayalew, Almaz
Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title_full Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title_fullStr Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title_full_unstemmed Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title_short Pulmonary Function Tests and Their Associated Factors Among Type 2 Diabetic Patients at Jimma Medical Center, in 2019; Comparative Cross-Sectional Study
title_sort pulmonary function tests and their associated factors among type 2 diabetic patients at jimma medical center, in 2019; comparative cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152549/
https://www.ncbi.nlm.nih.gov/pubmed/32308467
http://dx.doi.org/10.2147/IJGM.S249683
work_keys_str_mv AT tesemaderejegemeda pulmonaryfunctiontestsandtheirassociatedfactorsamongtype2diabeticpatientsatjimmamedicalcenterin2019comparativecrosssectionalstudy
AT gobenateshome pulmonaryfunctiontestsandtheirassociatedfactorsamongtype2diabeticpatientsatjimmamedicalcenterin2019comparativecrosssectionalstudy
AT ayalewalmaz pulmonaryfunctiontestsandtheirassociatedfactorsamongtype2diabeticpatientsatjimmamedicalcenterin2019comparativecrosssectionalstudy